CD45 immunoaffinity depletion of vesicles from Jurkat T cells demonstrates that exosomes contain CD45: no evidence for a distinct exosome/HIV-1 budding pathway
2008

CD45 Depletion from Jurkat T Cell Vesicles Shows Exosomes Contain CD45

Sample size: 8 publication Evidence: moderate

Author Information

Author(s): Coren Lori V, Shatzer Teresa, Ott David E

Primary Institution: AIDS and Cancer Virus Program, SAIC-Frederick, Inc., National Cancer Institute at Frederick, Frederick, Maryland, USA

Hypothesis

Do exosomes from Jurkat T cells contain CD45, and can they be removed from HIV-1 preparations using CD45 immunoaffinity depletion?

Conclusion

The study demonstrates that exosomes from Jurkat and SupT1/CCR5 cells contain CD45 and can be effectively removed from HIV-1 preparations.

Supporting Evidence

  • CD45 is excluded from HIV-1 but present in vesicles from hematopoietic cells.
  • Immunoblotting showed that CD45 was removed from vesicle preparations after depletion.
  • Depletion effectively removed 95% of vesicular proteins from Jurkat E6-1 and 96% from SupT1/CCR5.

Takeaway

The researchers found that tiny bubbles called exosomes from certain immune cells have a protein called CD45, which can be taken out to make studying viruses easier.

Methodology

The study used CD45 immunoaffinity depletion to remove vesicles from HIV-1 preparations and analyzed the samples using immunoblotting and SDS-PAGE.

Limitations

Absolute biochemical purity of virion preparations may not be practically attainable.

Participant Demographics

The study involved Jurkat and SupT1/CCR5 cell lines, which are commonly used for HIV-1 production.

Digital Object Identifier (DOI)

10.1186/1742-4690-5-64

Want to read the original?

Access the complete publication on the publisher's website

View Original Publication